Mitigation of contrast-induced nephropathy
US9421330B2 · kind B2 · utility
10Cited by
358References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 3, 2009 |
| Grant date | Aug 23, 2016 |
| Priority date | — |
| Expiry date | Oct 9, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2210/1082
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A system which includes a pressurizing mechanism to pressurize a fluid including a contrast enhancement agent for delivery to a patient and a control system in operative connection with the pressurizing mechanism. The control system includes a system to adjust control of fluid injection based upon a measurement of renal function of the patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.